Právní předpis byl sestaven k datu 01.01.2014.
Zobrazené znění právního předpisu je účinné od 01.01.2014 do 30.09.2015.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
463
XXXXXXXX VLÁDY
ze dne 18. xxxxxxxx 2013
x xxxxxxxxx xxxxxxxxxx látek
Vláda xxxxxxxx xxxxx §44c xxxx. 1 zákona x. 167/1998 Sb., x návykových xxxxxxx x x xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx znění xxxxxx x. 273/2013 Xx.:
§1
Xxxx xxxxxxxx stanoví
a) x příloze č. 1 x xxxxxx nařízení xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Seznamu X xxxxx Xxxxxxxx xxxxxx x omamných látkách1) x
2. xxxxxxx omamných xxxxx, x xxxxx xx z důvodu xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, že xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx povolení x xxxxxxxxx, nebo xx z xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx tyto omamné xxxxx xxxx xxxxxxxx x xxxxxxx xxxxx xx recept nebo xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx z xxxxxx dolního rohu xx xxxxxxx horního xxxx,
(xxxx xxx "xxxxxx x. 1 xxxxxxxx xxxxx"),
x) x příloze č. 2 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XX podle Jednotné xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx omamné xxxxx xxxx xxxxxxxx v xxxxxxx xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx modrým xxxxxx,
(xxxx xxx "xxxxxx x. 2 xxxxxxxx látek"),
c) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Jednotné xxxxxx x omamných xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx zdraví, nutné xxxxxxxxxx, xxx xxxxx x xxxxxxxxx obsahující xxxx xxxxxx látky xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx a velmi xxxxxxxx xxxxxxxxxxxxx účelům xxxxxxxxx v povolení x xxxxxxxxx,
(xxxx xxx "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 x xxxxxx xxxxxxxx seznam
1. psychotropních xxxxx xxxxxxxxxx xx Xxxxxxx I xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx2) x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx ohrožují xxxxxx, xxxxx zabezpečit, xxx xxxxx a xxxxxxxxx xxxxxxxxxx xxxx psychotropní xxxxx xxxx xxxxxxxxx xxxxx x omezeným xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx x zacházení,
(dále xxx "seznam č. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu XX xxxxx Úmluvy x xxxxxxxxxxxxxx látkách a
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x nimiž xx x důvodu xxxxxxx xxxxxx zneužívání anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx x tohoto xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx psychotropní xxxxx xxxx vydávány v xxxxxxx xxxxx na xxxxxx xxxx xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx xxxx do xxxxxxx horního xxxx,
(xxxx xxx "xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 k xxxxxx nařízení seznam xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu III xxxxx Xxxxxx o xxxxxxxxxxxxxx látkách,
x) x příloze č. 7 x tomuto xxxxxxxx xxxxxx
1. psychotropních xxxxx zařazených do Xxxxxxx XX podle Xxxxxx o psychotropních xxxxxxx x
2. dalších xxxxxxxxxxxxxx látek, x xxxxx je z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx bezprostředně nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxx byly xxxxxxxx x lékárně xx recept nebo xxxxxxx xxx označení xxxxxx xxxxxx,
(xxxx xxx "xxxxxx x. 7 xxxxxxxxxxxxxx látek"), x
x) x příloze č. 8 x xxxxxx nařízení xxxxxx xxxxxxxxx zařazených do Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx,
(xxxx xxx "xxxxxx č. 8 xxxxxxxxx xxxxxxxxx").
§2
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady 98/34/ES ze dne 22. xxxxxx 1998 x postupu při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro služby xxxxxxxxxx společnosti, x xxxxxxx xxxxx.
§3
Toto nařízení nabývá xxxxxxxxx dnem 1. xxxxx 2014.
Příloha x. 1 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 1 omamných xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) piperidin-4-yl}-N-fenylpropanamid |
|
|
Allylprodin |
3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Anileridin |
elhyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát |
|
|
Benzethidin |
ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát |
|
|
Benzylmorfin |
3-(bertzyIoxy)-4.5α-epoxy-17-methylmorfin-7-en-6α-ol |
|
|
Betacethylmethadol |
(3S,6R)-6-{dimethylameno )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx kyselina |
|
|
Difenoxylát |
ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Dihydroetorfin |
(5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1X,2X,3X,5X)-3-xxxxxxx-8-xxxxxx-9-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x deriváty, x kterých xx xxxxx xxxxxx ekgonin x xxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx- 3-xxxxxxxxxx-8-xx |
|
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) xxxxx]xxx}xxxxxx |
|
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- xxxxxxxxxx |
|
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx alkaloidů xxxxxxx xxxxxxxxxxxxxx xxxxxxx makoviny |
|
|
Konopí xxxxxxx a xxxxxxxx |
Xxxxxxx x xxxxxxxx x xxxxxx |
|
|
Xxxxxx pro xxxxxxx xxxxxxx |
xxxxxx xxxxxx x xxxxxxxx léčivých přípravků xx standardizovaným xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx dextromethorfan [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] je vyňat xx xxxxxxx omamných xxxxx uvedených x xxxx příloze |
|
Levomoramid |
(3R)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
|
Levorfanol |
(9R,13R,14R)-17-methylmorfinan-3-ol |
Stereoizomerní xxxxxxxxxxx [(+)-3-xxxxxxx-17- methylmorfinan] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x této xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxx, meziprodukt |
2,2-difenyl-3-methyl-4-rnorfolinobutanová xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x jiné xxxxxxxx xxxxxxx se xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx xxxxxx-X-xxxxx (i xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx homeopaticky xxxxxxxxxx přípavků, xxxxxxx xxxxxx xxxxxx je xxxxx než D4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxXxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, meziprodukt X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx C |
kyselina 4-fenyl-1-methylpiperidin-4-karboxylová |
|
|
Piminodin |
ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Piritramid |
1'-(3,3-difenyl-3-kyanpropyl-4'-ureido-1,4'-bipiperidin |
|
|
Proheptazin |
4-fenyl-1,3-dimethylazepan-4-yl-propanoát |
|
|
Properidin |
isopropyI-4-fenol-1-methylpiperidin-4-karboxylát |
|
|
Racemethorfan |
(9RS,13RS,14RS)-3-methoxy-17-methylmorfinan |
|
|
Racernoramid |
(3RS)-2,2-dyfenil-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
|
Racemorfan |
(9RS,13RS,14RS)-17-methylmorfinan-3-ol |
|
|
Rernifentanil |
methyl-3-[4-(N-acetonylanilono)4-(methoxykarbonyl)]piperidino]propanoát |
|
|
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tapentadol |
3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol |
|
|
Thebain |
4,5α-epoxy-3,6-dimethoxy-17-triethylmorfina-6,8-dien |
|
|
Thebakon |
(5R)-4,5-epoxy-3-methoxy-17-methyImorfin-6-en-6-yl-acetát |
|
|
Thiofentanyl |
N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tilidin |
ethyl-(1RS,2RS)-2-(dimethylamono)-1-fenylcyklohex-3-en-1-karboxylát |
|
|
Trimeperidin |
(RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Včetně xxxxxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx estery x xxxxxx xxxxxxxx xxxxx xxxxxxxxx v xxxxx xxxxxxx x xxxx xxxxxxxx látek xxxxxxxxx x tomto xxxxxxx včetně xxxx xxxxxxx, xxxxxx x xxxxx ve všech xxxxxxxxx, kdy xxxx xxxx mohou existovat.
Xxxxxxx č. 2 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu, xxxx xxxx xxxxxxxx látek xxxxxxxxx x xxxxx xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx existovat.
Xxxxxxx č. 3 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 3 xxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) v českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-methyl-6,14-ethenomorfinan-3-ol |
|
|
Heroin |
(5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát |
|
|
Ketobemidon |
1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on |
|
|
Konopí |
S xxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx xxxxxxx x xxxxxxx č. 1 |
|
|
Xxxxxxxxxx x xxxxxx |
Xxxxxx solí xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
XX-2201 |
[1-{5-xxxxxxxxxxx}-1X--xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
||
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
xx-XXXX |
1-(4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-{4-xxxx-2,5-xxxxxxxxxxxxxx}xxxxxx-2-xxxx |
|
|
Xxxxx-Xxxxxxxxx |
1-(8-xxxxxxxxxx[1,2-x']xxxxxxx-4-xx)xxxxxx 2-xxxx |
||
|
Xxxxxxx |
2-(xxxxxXxxxxx)-1-(3,4-(xxxxxxxxxxxxx)xxxxx)xxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-1 |
(4-xxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxxx |
2X-X-7 |
[2,5-xxxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
||
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-{2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X- benzo[c]chromen-1-ol |
|
|
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin |
|
|
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
||
|
Dimethoxyethylamfetamin |
DOET |
(2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin |
|
|
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
||
|
Eticyklidin |
PCE |
N-ethyl-1-fenylcyklohexylamin |
|
|
Etryptamin |
3-(2-aminobutyl)indol |
||
|
Flefedron |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
||
|
4-FMA |
1-(4-fluofenyl)-N-methylpropan-2-amin |
||
|
JWH-018 |
(naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)rnethanon |
||
|
JWH-081 |
(4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-122 |
(4-methylnaftalen-1-yl)(1-pentyI-1H-indol-3-yl)methanon |
||
|
JWH-200 |
[1-{2-morfolinoethyl)-1H-indol-3-yl](naftalen-1-yl)methanon |
||
|
JWH-250 |
2-(2-methoxyfel)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on |
||
|
JWH-398 |
(4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
Kathion |
(2S)-2-amino-1-fenylpropan-1-on |
||
|
(+)-Lysergid |
LSD, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
4-Xxxxxxxxxxxx |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
||
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
4-XXX |
2-[xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2xxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx ?? |
||
|
pFPP |
1-(4-fluorfenyl)piperazin |
||
|
Methoxyamfetamin |
PMA |
(2RS)-1-(4-methoxyfenyl)propan-2-amin |
|
|
Methoxymetamfetamin |
PMMA |
1-(4-methoxyfenyl)-N-methylpropan-2-amin |
|
|
Psilocybin |
3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogen-fosfát |
||
|
Psilocin |
Psilotsin |
3-[2-(dimethylamino)ethyl]-1H-indol-4-ol |
|
|
Rolicyklidin |
PHP, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3 -xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxx[x]xxxxxxxxxx- 7-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
XXXXX |
1-[3-(xxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-,Δ6x(7)-,Δ7-,Δ8-,Δ10-,Δ9(11)-xxxxxxxxxxxxxxxxxxxx x xxxxxx stereoizomery |
|
|
Trimethoxyamfetamin |
TMA |
(2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin |
|
|
Trimethoxyamfetamin-2 |
TMA-2 |
(2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin |
Včetně stereaizomerů xxxxxxxxxxxxxx xxxxx, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx zvláštního chemického xxxxxxxx x solí xxxxxxxxxxxxxx xxxxx uvedených x xxxxx seznamu xx xxxxx případech, xxx mohou xxxxxxxxx.
Xxxxxxx č. 5 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 5 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxx racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (THC) a xxxx xxxxxxxxxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 6 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 psychotropních xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-allyl-5-isobutylbarbiturová |
||
|
Cyklobarbital |
kyselina 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx xxxxx uvedených x xxxx skupině xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Příloha č. 7 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X.[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxxx)-X-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
7-xxxx-5.(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x]xxxxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- xxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
|
Fenproprex |
(±)-1-fenyl-2-[(2-kyanethyl)amino]propan |
||
|
Fentemin |
2-fenyl-1,1-dimethylethylamin |
||
|
FIudiazepam |
7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2G-1,4-benzodiazepin-2-on |
||
|
FIurrazepam |
7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-bezodiazepin- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5X)-xx |
||
|
Xxxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxXxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxx xxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2,1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxxx[1,5-α][1,4]xxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
5-xxxxX-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -xxxxxxxxxx-4-xx |
||
|
Xxxxxxxxx |
7-xxxxxx-4-xxxxx-1-(xxxx-2-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
xxxxxxX(2-xxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxxxxxx)xxxxxxxxxxx kyselina |
||
|
Temazepam |
(RS)-7-chlor-5-fenyl-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Tetrazepam |
7-chlor-5-(cyklohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-1,4-bezodiazepin-2-on |
||
|
Triazolamn |
8-chlor-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-α][1,4]benzodiazepin |
||
|
Vinylbital |
5-(1-methylbutyl)-5-vinylbarbiturová xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx solí xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Xxxxxxx x. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx více xxxxxxx xxxxx (nikoliv xxxx xxxxxxxx) x xxxxxxxx omamné látky |
|
|
a) |
v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
|
x) |
x roztoku xxxxx xxx koncentrace xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, příp. x xxxx lékové xxxxx 0,5 mg. |
|
b) |
Množství xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxx, xxxxxx, čípku, xxxx. xxxx xxxxxx xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x jedné xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v jiné xxxxxx formě 2,5 xx. |
|
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx xxxxxxx 1 % x množství xxxxxxxxxxxx v xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. v xxxx lékové xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx xxxxxxxxxx 135 xx x jedné xxxxxxx, tobolce, ampuli, xxxxx, příp. x xxxx lékové formě. |
||
|
b) |
v xxxxxxx xxxxx xxx xxxxxxxxxxx vyšší než 2,5 %. |
||
|
Xxxxxxxxx xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx kokainu xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx morfin |
a) |
Množství xxxxxxx nesmí xxxxxxxxxx 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx jednu nebo xxxx dalších xxxxx (xxxxxxx xxxx omamných). |
||
|
Omamná xxxxx v xxxxxxxxx xxxxxxxx nesmí být xxxxxx získána zpět x xxxxxxx xxxxxxxx, xxx xxxxxxxx veřejné xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx prášek s xxxxx |
x) |
Xxxxxxxx opia v xxxxxx xxxxx xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx ipekakuanhového xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
x} |
Xxxxxxxx xxxxx xxxx více xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxxx) xxxxx xxx xxxxx xxx 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx propiramu xxxxx xxxxxxxxxx 100 mg x jedné xxxxxxx, xxxxxxx, ampuli, čípku, xxxx. v xxxx Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx methylcelulosy x xxxxxxxxx xxxx xxx xxxxxxx xxxxxx xxxx xxxxx xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, jejichž stupeň xxxxxx xx xxxxx xxx X4 xxxx XX2.
Xxxxxx xxxxxxx č. 463/2013 Sb. xxxxx xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx x doplnění xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx se mění xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx návykových látek, xx xxxxx nařízení xxxxx x. 243/2015 Xx.
x účinností od 1.3.2017 x výjimkou xxxxxxxxx ustanovení, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s účinností xx 8.3.2018
242/2018 Xx., xxxxxx se mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x účinností xx 25.10.2018
184/2021 Xx., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx od 3.6.2021
159/2022 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2022
228/2023 Sb., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx mění xxxxxxxx vlády č. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 1.7.2024 a 1.1.2025
419/2024 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.1.2025 a 1.4.2025
534/2025 Xx.,&xxxx;xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů, a xxxxxxxx xxxxx x. 11/2025 Xx., x xxxxxxx xxxxxxxxxx psychoaktivních xxxxx
x xxxxxxxxx xx 16.12.2025 s výjimkou xxxxxxx č. 5, xxxxx xxxxxx xxxxxxxxx 1.1.2026
50/2026 Xx.,&xxxx;xxxxxx se xxxx nařízení vlády x. 458/2013 Sb., x seznamu xxxxxxxxx x xxxxxxxxx látek x jejich ročních xxxxxxxxxxxx xxxxxxxx, xx xxxxx pozdějších xxxxxxxx, xxxxxxxx vlády x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx, x nařízení xxxxx x. 11/2025 Xx., x xxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxx, xx znění xxxxxxxx xxxxx č. 534/2025 Xx.
x xxxxxxxxx od 3.4.2026
107/2026 Sb., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech návykových xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, x xxxxxxxx xxxxx č. 11/2025 Xx., o xxxxxxx zařazených xxxxxxxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx předpisů
s účinností xx 25.6.2026
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxx pod č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Xxxxxx o xxxxxxxxxxxxxx xxxxxxx, vyhlášená xxx č. 62/1989 Sb.